Adarx
All
Newsflash
Article
-
Adarx Pharmaceuticals Raises $446.3 Million in Upsized US IPO
Adarx Pharmaceuticals Inc., a San Diego-based late-stage developer of gene therapies, raised $446.3 million in an upsized initial public offering on Thursday. The company priced its shares at the top
-
Adarx Pharmaceuticals Raises $446.3 Million in Upsized US IPO
Adarx Pharmaceuticals Inc., a San Diego-based late-stage developer of gene therapies, raised $446.3 million in an upsized initial public offering on Thursday. The company priced its shares at the top
- No data
Adarx
Svmuu provides news and information related to Adarx, as well as real-time data on Adarx. We provide in-depth analysis and interpretation of the latest Adarx developments, helping investors stay informed about Adarx policy updates. Svmuu is your essential tool for keeping up with the latest Adarx trends! Here, we’ll join you in keeping a close eye on Adarx news and use a clear macro perspective to make sense of the uncertain future of crypto.
24H Trending
-
1
Reviewing Bitcoin's Historical Performance Amid Geopolitical Conflicts: From Flash Crash to V-Shaped Recovery—True Safe-Haven Asset or High Volatility?
-
2
What is Computing Power? A Comprehensive Analysis from Concept to Market
-
3
DNT Issue Price at 0.1 Yuan? Current Status and Risks of district0x
-
4
Verification of DOGEBLUE Coin Purchase Channels and Long-Term Holding Risk Analysis
-
5
Current Status and Long-Term Investment Value Analysis of TajCoin (TAJ)
-
6
How to Trade KRX Tokens? Current Listed Exchanges and Risk Warnings
-
7
What is Cryptocurrency? A Review of the Top 5 Cryptocurrencies by Market Cap in 2026
-
8
What is TBX? Current Status of Tokenbox Tokens and Trading Channels
-
9
What is the value of the JavaScript token? Is it worth a long-term investment?
-
10
1MIL Token Analysis: Project Positioning and High-Risk Attributes
Markets Today
Recommended Reading









